搜索临床试验以:Invasive breast cancer stages II-III
总计93845个结果
-
Sidney Kimmel Cancer Center at Thomas Jefferson...完全的IA期乳腺癌 | IB 期乳腺癌 | 复发性乳腺癌 | 乳腺导管原位癌 | 浸润性小叶乳腺癌 | 小叶性乳腺癌原位癌 | 浸润性导管癌美国
-
Fondazione MichelangeloHoffmann-La Roche主动,不招人
-
Fondazione Michelangelo完全的
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of Texas主动,不招人
-
Tomsk National Research Medical Center of the Russian...Uppsala University完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)暂停解剖学 I 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 浸润性乳腺癌 | 激素受体阳性乳腺癌 | 乳腺导管原位癌 | HER2 阴性乳腺癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials Group主动,不招人
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | BRIP1基因突变 | PALB2基因突变 | ATM基因突变 | CHEK2基因突变 | NBN基因突变 | RAD51基因突变 | 体细胞突变乳腺癌 (BRCA1) | 体细胞突变乳腺癌 (BRCA2)美国
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | 浸润性乳腺癌 | II期乳腺癌 | 乳腺癌女性 | HER2阳性乳腺癌 | III期乳腺癌美国
-
H. Lee Moffitt Cancer Center and Research InstituteAmgen主动,不招人
-
National Cancer Institute (NCI)主动,不招人临床 III 期皮肤黑色素瘤 AJCC v8 | 粘膜黑色素瘤 | 肢端黑色素瘤 | 临床 IV 期皮肤黑色素瘤 AJCC v8美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Halozyme Therapeutics完全的
-
Istari Oncology, Inc.United States Department of Defense; Duke University完全的
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人复发性结肠癌 | 复发性直肠癌 | 直肠腺癌 | 结肠腺癌 | ERBB2基因扩增 | III 期结肠癌 AJCC v7 | III 期直肠癌 AJCC v7 | IIIA 期结肠癌 AJCC v7 | IIIA 期直肠癌 AJCC v7 | IIIB 期结肠癌 AJCC v7 | IIIB 期直肠癌 AJCC v7 | IIIC 期结肠癌 AJCC v7 | IIIC 期直肠癌 AJCC v7 | IV 期结肠癌 AJCC v7 | IV 期直肠癌 AJCC v7 | IVA 期结肠癌 AJCC v7 | IVA 期直肠癌 AJCC v7 | IVB 期结肠癌 AJCC v7 | IVB 期直肠癌 AJCC v7美国, 波多黎各
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials Group主动,不招人
-
National Cancer Institute (NCI)主动,不招人浸润性乳腺癌 | 三阴性乳腺癌 | II 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人III 期结肠癌 AJCC v8 | III 期直肠癌 AJCC v8 | IIIA 期结肠癌 AJCC v8 | IIIA 期直肠癌 AJCC v8 | IIIB 期结肠癌 AJCC v8 | IIIB 期直肠癌 AJCC v8 | IIIC 期结肠癌 AJCC v8 | IIIC 期直肠癌 AJCC v8 | IIA 期直肠癌 AJCC v8 | IIB 期直肠癌 AJCC v8 | II 期直肠癌 AJCC v8 | IIC 期直肠癌 AJCC v8 | I 期直肠癌 AJCC v8 | IIA 期结肠癌 AJCC v8 | IIB 期结肠癌 AJCC v8 | IIC 期结肠癌 AJCC v8 | I 期结肠癌 AJCC v8 | II 期结肠癌 AJCC v8美国
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | III期乳腺癌 | 绝经后 | 雌激素受体状态美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.主动,不招人
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人恶心 | 便秘 | 腹泻 | 紫癜 | 淋巴结肿大 | 消化道出血 | 肝肿大 | 原发性系统性淀粉样变性 | 无定形、嗜酸性和无细胞沉积物 | 早饱 | 巨舌症 | 复发性原发性淀粉样变性 | 难治性原发性淀粉样变性美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn Medicine完全的
-
Dana-Farber Cancer InstituteMyriad Genetics, Inc.主动,不招人
-
HKGepitherapeuticsKazakh Research Institute of Oncology & Radiology; Montreal EpiTerapia Inc.; Canada-Kazakhstan...终止
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人
-
University of NebraskaNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 孕激素受体阳性 | 三阴性乳腺癌 | III期乳腺癌美国
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research Group (SOLTI)主动,不招人HER2阳性原发性乳腺癌 | 残留浸润性乳腺癌美国, 西班牙, 法国, 德国, 大韩民国, 英国, 丹麦, 以色列, 比利时, 台湾, 智利, 意大利, 日本, 秘鲁, 葡萄牙, 中国, 火鸡, 加拿大, 爱尔兰, 澳大利亚, 希腊, 捷克语, 新加坡, 波兰, 罗马尼亚, 阿根廷, 巴西, 香港, 墨西哥, 荷兰, 俄罗斯联邦
-
National Cancer Institute (NCI)Canadian Cancer Trials Group主动,不招人急性淋巴细胞白血病 | B 急性淋巴细胞白血病,费城染色体阴性美国, 加拿大, 以色列, 波多黎各
-
Namida LabThe University of Texas Medical Branch, Galveston主动,不招人
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)主动,不招人IVA 期肺癌 AJCC v8 | IVB 期肺癌 AJCC v8 | IV 期肺癌 AJCC v8 | 复发性肺非小细胞癌美国
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene Corporation主动,不招人
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University Marburg主动,不招人
-
Dana-Farber Cancer InstitutePatient-Centered Outcomes Research Institute主动,不招人